The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

For almost two decades, scientists have debated whether sponges or comb jellies are the first animal lineage. Now some are ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

For example, in Greenwood’s Grade 12 kinesiology program, students not only learn skills in the classroom, but design a rehab ...

Discover 10 top online IT certifications that boost tech job prospects and supercharge your tech career training with ...

In this unusually eventful — mostly not in good ways — year for higher education, it’s salutary to be reminded how much good ...

Terrorist attacks, whether by individuals or groups, are usually followed by attempts to explain the rationale and causes behind them. The core reasons, ...

A Decent AI Chatbot With Fantastic Tie-Ins ...

Officials in Reedley, California said they had tried to warn federal authorities about the possibility of similar labs after ...

A new batch of more than three million pages of investigative files about Jeffrey Epstein that was released by the Department ...

Spin-out Merge Labs aims to rival Elon Musk’s brain-chip company Neuralink. But researchers say the technology is still at an early stage.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the first public showcase of QIAsprint Connect at SLAS 2026 in Boston, marking QIAGEN’s entry into high-throughput benchtop ...